GeriatricsMoCANCT02558907
Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology
An observational study of Geriatrics and Cancer, run by Centre Francois Baclesse at 2 sites in France.
Trial summary
Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric Read more about this study
- Who is it for?
- Ages 71 years and older
- Conditions the study is for
- Geriatrics, Cancer
- What is being tested?
- cognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests
- How many people
- 66 participants
- Where
- 2 sitesFrance
- Study dates
- Sep 2015to Mar 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 71 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: aged patients with 1st line treatment of their cancer will be received an examination oncogériatric
Who may be able to join
- Patient old over 70 years
- Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned
- Patient candidate an oncogeriatric assessment
- Patient agreeing to participate in the study
- French language
- Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder
- Patient having a life expectancy ≥ 6 months
Who cannot join
- Primitive cancer of the central nervous system or brain metastasis
- Patients unable to meet the cognitive tests
- Refusal to participate
- Realization of a MMSE or MoCA test in the last 6 months
Trial locations and contacts
2 sites in 1 country.
About this study
Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric
- Conditions
- Geriatrics, Cancer
- Being tested
- cognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests
- Keywords
- geriatrics, cancer, MMS test, MoCA test, cognitive evaluation
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) testsOther
What is being measured
The primary outcome is the main question the study is designed to answer.
proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment
Measured: before their first treatment for the cancer, at inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Sep 2015 (estimated)
- Study startSep 2015
- Primary completionMar 2017
- Study completionMar 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GeriatricsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 66 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Francois Baclesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Heidi LAVIEC, MD, Principal investigator, Centre François Baclesse - CAEN
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02558907
- Sponsor's protocol ID
- MoCA
- Acronym
- MoCA
- Status last verified
- Jun 2016
- First submitted
- 18 Sep 2015
- Last updated
- 4 Apr 2017
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology
- ClinicalTrials.gov ID
- NCT02558907
- Acronym / sponsor ID
- MoCA / MoCA
- Conditions
- Geriatrics, Cancer
- Keywords
- geriatrics, cancer, MMS test, MoCA test, cognitive evaluation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 66 participants (actual)
- Lead sponsor
- Centre Francois BaclesseUniversity, hospital or other
- Study start
- Sep 2015 (actual)
- Primary completion
- Mar 2017 (actual)
- Study completion
- Mar 2017 (actual)
- First posted
- 24 Sep 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 71 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- aged patients with 1st line treatment of their cancer will be received an examination oncogériatric
Key inclusion criteria (7 listed)
- Patient old over 70 years
- Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned
- Patient candidate an oncogeriatric assessment
- Patient agreeing to participate in the study
- French language
Key exclusion criteria (4 listed)
- Primitive cancer of the central nervous system or brain metastasis
- Patients unable to meet the cognitive tests
- Refusal to participate
- Realization of a MMSE or MoCA test in the last 6 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests | Other | – |
Primary outcome
proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment
Time frame: before their first treatment for the cancer, at inclusion
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2017.
Related trials for Geriatrics
Enrolling by invitationObservational study
Comorbidity, Cognition, Gait Speed, and Respiratory Muscle Strength in Older Adults
Geriatrics, Older Adults (60 - 85 Years Old)
RecruitingObservational study
Multimodal Assessment of Sarcopenia Using Shear Wave Elastography, Dual-Energy X-ray Absorptiometry, Bioelectrical Impedance Analysis, and Physical Performance Measures
Sacropenia
Active, not recruiting
Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions
Prescribing Decisions, Diabetes
Not yet recruiting
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
Valvular Heart Disease Patients, Aortic Stenosis
RecruitingObservational study
Physiotherapy Practice in Flemish Nursing Homes
Guideline Implementation, Physiotherapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heidi LAVIEC, MD principal investigator
Centre François Baclesse - CAEN
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Geriatrics and Cancer, run by Centre Francois Baclesse at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment (time frame: before their first treatment for the cancer, at inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2017.